Mirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

Explore the causes of itching in liver diseases and tips to relieve discomfort. Learn about treatments for pruritus and when ...

Vaginal itching has many possible causes, ranging from common yeast infections and irritants like soap to skin conditions, vaginitis, and sexually transmitted infections (STIs). These conditions cause ...

Private area itching can transform from a minor annoyance into a significant disruption to daily life, affecting confidence and comfort. While the topic might feel awkward to discuss ...

Pruritus is associated with health-related quality of life in patients with primary biliary cholangitis (PBC), confirms a new study published in the journal Hematology Communications. The authors said ...

Itchy skin, or pruritus, can result from conditions like eczema or dermatitis. Less commonly, it can stem from conditions such as kidney failure and liver disease. Some causes of itching affect ...

Sometimes, it may be a symptom of an underlying condition. Itchy skin at night, called nocturnal pruritus, can be severe enough to disrupt sleep regularly. Why this happens can range from natural ...

2Dr. Li Dak-Sum Research Centre, the University of Hong Kong, Hong Kong 3Department of Surgery, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong 4Department of Surgery, ...

Someone may experience itching around the vulva and vagina for several possible reasons. For example, vaginal itching or irritation may be due to contact with fabrics or scented soaps, yeast ...

Volixibat VANTAGE study in primary biliary cholangitis (PBC) expected to complete enrollment in 2026. LIVMARLI EXPAND Phase 3 study for pruritus in rare cholestatic conditions expected to complete ...

Volixibat VANTAGE study in primary biliary cholangitis (PBC) expected to complete enrollment in 2026. LIVMARLI EXPAND Phase 3 study for pruritus in rare cholestatic conditions expected to complete ...